eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank

4/2018
vol. 43
 
Share:
Share:
more
 
 
abstract:
Review paper

Impact of polyphenols on mast cells with special emphasis on the effect of quercetin and luteolin

Yasdani Shaik, Alessandro Caraffa, Gianpaolo Ronconi, Gianfranco Lessiani, Pio Conti

(Centr Eur J Immunol 2018; 43 (4): 476-481)
Online publish date: 2018/12/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Polyphenols are ubiquitous in food and have long been recognized to possess antioxidant, anti-inflammatory and anticancer activities. Mast cells (MCs) are implicated in the pathogenesis of inflammatory diseases, allergy, autoimmunity and cancer. MCs derive from hematopoietic progenitor cells, reside virtually in all vascularized tissue and are activated by crosslinking of FceRI-bound IgE (at very high affinity: 1 × 1010 M-1) with multivalent antigen. MCs in cytoplasmic granules release preformed chemical mediators, and also they can release lipid mediators and cytokines/chemokines without degranulation.

Luteolin, 3’,4’,5,7-tetrahydroxyflavone, is a flavonoid contained in many kinds of plants including vegetables and fruits. This anti-oxidant product inhibits interleukin (IL)-6, IL-8 and vascular endothelial growth factor (VEGF) production from tumor necrosis factor (TNF)-triggered keratinocytes, and is a candidate for use in alternative therapies in the treatment of inflammatory skin disorders.

Quercetin (3,3’,4’,5,7-pentahydroxyflavone) is a ubiquitous flavonoid which exhibits anti-cancer, anti-oxidative and anti-inflammatory properties and causes a reduction in the availability of nitrite that influences vascular function. Quercetin exerts physiological functions though the interaction with phosphatidylinositol-3-phosphate kinase (PI3K), mitogen-activated protein kinase (MAPK), extracellular signal regulated kinase (ERK), kinase (MEK) 1, and others, and has a negative effect on FceRI cross-linking and other activating receptors on mast cells. In this article we report for the first time the interrelationship between mast cells and polyphenols.
keywords:

polyphenols, mast cells, immunity, inflammation

references:
Nahrstedt A, Schmidt M, Jäggi R, et al. (2007): Willow bark extract: the contribution of polyphenols to the overall effect. Wien Med Wochenschr 157: 348-351.
King L, Tsilioni I, Theoharides TC (2018): Time to look past TNF and thalidomide for cachexia – could mast cells and flavonoids be the answer? J Biol Regul Homeost Agents 32: 443-447.
Molitor C, Mauracher SG, Rompel A (2016): Aurone synthase is a catechol oxidase with hydroxylase activity and provides insights into the mechanism of plant polyphenol oxidases. Proc Natl Acad Sci U S A 113: E1806-1815.
Osawa T (1999): Protective role of dietary polyphenols in oxidative stress. Mech Ageing Dev 111: 133-139.
Liu CL, Yan L, Cai KR, et al. (2018): Effects of soybean isoflavones on Wnt/-catenin and the TGF-1 signaling pathway in renal tissue of type 2 diabetic rats. J Biol Regul Homeost Agents 32: 455-464.
Bahramsoltani R, Farzaei MH, Farahani MS, Rahimi R (2015): Phytochemical constituents as future antidepressants: a comprehensive review. Rev Neurosci 26: 699-719.
Yaniv SP, Lucki A, Klein E, Ben-Shachar D (2010): Dexamethasone enhances the norepinephrine-induced ERK/MAPK intracellular pathway possibly via dysregulation of the alpha2-adrenergic receptor: implications for antidepressant drug mechanism of action. Eur J Cell Biol 89: 712-722.
Li AN, Li S, Zhang YJ, et al. (2014): Resources and biological activities of natural polyphenols. Nutrients 6: 6020-6047.
Youdim KA, Joseph JA (2001): A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic Biol Med 30: 583-594.
Kawabata K, Mukai R, Ishisaka A (2015): Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. Food Funct 6: 1399-1417.
Gebicka L, Banasiak E (2009): Flavonoids as reductants of ferryl hemoglobin. Acta Biochim Pol 56: 509-513.
Albini A, Tosetti F, Li VW, et al. (2012): Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol 9: 498-509.
Yasueda A, Urushima H, Ito T (2016): Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review. Integr Cancer Ther 15: 17-39.
Chen S (2011): Natural products triggering biological targets – a review of the anti-inflammatory phytochemicals targeting the arachidonic acid pathway in allergy asthma and rheumatoid arthritis. Curr Drug Targets 12: 288-301.
Cárdeno A, Sánchez-Hidalgo M, Aparicio-Soto M, et al. (2014): Extra virgin olive oil polyphenolic extracts downregulate inflammatory responses in LPS-activated murine peritoneal macrophages suppressing NFB and MAPK signalling pathways. Food Funct 5: 1270-1277.
Bao L, Alexander JB, Shi VY, et al. (2014): Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites. Immunology 143: 601-608.
Granato T, Anastasi E, Viggiani V, et al. (2018): Serum 25-hydroxy vitamin D levels in essential hypertension. J Biol Regul Homeost Agents 32: 1599-1604.
Jasinska T, Wyszyska-Chlap M, Kasperski J, Kasperska-Zajac A (2015): Plasma soluble CD40 concentration in patients with delayed pressure urticaria. Eur J Inflamm 13: 126-129.
Hussain F, Irshad A, Shahid M (2018): Study of selected therapeutic potentials of Momordica charantia fruit. J Biol Regul Homeost Agents 32: 859-862.
Pałgan K, Bartuzi Z (2015): Platelet activating factor in allergies. Int J Immunopathol Pharmacol 28: 584-589.
Cottrell GS, Coelho AM, Bunnett NW (2002): Protease-activated receptors: the role of cell-surface proteolysis in signalling. Essays Biochem 38: 169-183.
Floreani AA, Rennard SI (1997): Experimental treatments for asthma. Curr Opin Pulm Med 3: 30-41.
Theoharides TC, Enakuaa S, Sismanopoulos N, et al. (2012): Contribution of stress to asthma worsening through mast cell activation. Ann Allergy Asthma Immunol 109: 14-19.
Kurvers HA (1998): Reflex sympathetic dystrophy: facts and hypotheses. Vasc Med 3: 207-214.
Liu HW, Meng Y, Zhang J, et al. (2018): Role and influence of p75NTR receptor on antioxidative damage of retinal pigment epithelial cells. J Biol Regul Homeost Agents 32: 1379-1387.
Guan D, Li Y, Peng X, et al. (2018): Thymoquinone protects against cerebral small vessel disease: Role of antioxidant and anti-inflammatory activities. J Biol Regul Homeost Agents 32: 225-231.
Kempuraj D, Castellani ML, Petrarca C, et al. (2006): Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Clin Exp Med 6: 150-156.
Conti P, Pang X, Boucher W, et al. (1997): Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89: 4120-4127.
Kletke O, Sergeeva OA, Lorenz P, et al. (2013): New insights in endogenous modulation of ligand-gated ion channels: histamine is an inverse agonist at strychnine sensitive glycine receptors. Eur J Pharmacol 710: 59-66.
Beghdadi W, Porcherie A, Schneider BS, et al. (2008): Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease. J Exp Med 205: 395-408.
Weng Z, Zhang B, Asadi S, et al. (2012): Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One 7: e33805.
Plemel JR, Juzwik CA, Benson CA, et al. (2015): Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review. Mult Scler 21: 1485-1495.
Russo M, Spagnuolo C, Tedesco I, et al. (2012): The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 83: 6-15.
Olszanecki R, Gebska A, Kozlovski VI, Gryglewski RJ (2002): Flavonoids and nitric oxide synthase. J Physiol Pharmacol 53 (4 Pt 1): 571-584.
Kandere-Grzybowska K, Kempuraj D, Cao J, et al. (2006): Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol 148: 208-215.
Kyaw M, Yoshizumi M, Tsuchiya K, et al. (2004): Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases. Acta Pharmacol Sin 25: 977-985.
Nabavi SF, Russo GL, Daglia M, Nabavi SM (2015): Role of quercetin as an alternative for obesity treatment: you are what you eat! Food Chem 179: 305-310.
Kawabata K, Mukai R, Ishisaka A (2015): Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. Food Funct 6: 1399-1417.
Welton AF, Hurley J, Will P (1988): Flavonoids and arachidonic acid metabolism. Prog Clin Biol Res 280: 301-312.
Nam NH (2006): Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 6: 945-951.
Jeong E, Lee JY (2011): Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J 52: 379-392.
Middleton E Jr. (1986): Effect of flavonoids on basophil histamine release and other secretory systems. Prog Clin Biol Res 213: 493-506.
Peluso I, Miglio C, Morabito G, et al. (2015): Flavonoids and immune function in human: a systematic review. Crit Rev Food Sci Nutr 55: 383-395.
Theoharides TC, Conti P, Economu M (2014): Brain inflammation, neuropsychiatric disorders, and immunoendocrine effects of luteolin. J Clin Psychopharmacol 34: 187-189.
Lin Y, Shi R, Wang X, Shen HM (2008): Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8: 634-646.
Kempuraj D, Tagen M, Iliopoulou BP, et al. (2008): Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells. Br J Pharmacol 155: 1076-1084.
Weng Z, Patel AB, Vasiadi M, et al. (2014): Luteolin inhibits human keratinocyte activation and decreases NF-B induction that is increased in psoriatic skin. PLoS One 9: e90739.
Aneknan P, Kukongviriyapan V, Prawan A, et al. (2014): Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells. Asian Pac J Cancer Prev 15: 5071-5076.
George VC, Naveen Kumar DR, Suresh PK, et al. (2013): Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells. Asian Pac J Cancer Prev 14: 631-637.
Zhang H, Li X, Zhang Y, Luan X (2014): Luteolin induces apoptosis by activating Fas signaling pathway at the receptor level in laryngeal squamous cell line Hep-2 cells. Eur Arch Otorhinolaryngol 271: 1653-1659.
Hollman PC, Katan MB (1999): Health effects and bioavailability of dietary flavonols. Free Radic Res 31 Suppl: S75-80.
Miniati A, Weng Z, Zhang B, et al. (2014): Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin: relevance to early vitiligo. Clin Exp Dermatol 39: 54-57.
Kritas SK, Gallenga CE, D Ovidio C, et al. (2018): Impact of mold on mast cell-cytokine immune response. J Biol Regul Homeost Agents 32: 763-768.
Aragona SE, Grassi FR, Nardi G, et al. (2017): Photobiomodulation with polarized light in the treatment of cutaneous and mucosal ulcerative lesions. J Biol Regul Homeost Agents 31 (2 Suppl. 2): 213-218.
Nisticò S, Torchia V, Gliozzi M, et al. (2016): Pharmacoeconomy of drugs used in the treatment of actinic keratoses. Int J Immunopathol Pharmacol 29: 796-804.
Park SH, Choi H-J, Lee S, Han J-S (2015): TLR4-mediated IRAK1 activation induces TNF- expression via JNK-dependent NF-B activation in human bronchial epithelial cells. Eur J Inflamm 13: 183-195.
FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe